相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Progression of excitation-contraction coupling defects in doxorubicin cardiotoxicity
Anna Llach et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Molecular mechanism of doxorubicin-induced cardiomyopathy - An update
Kaviyarasi Renu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Cardioprotective Effects of Carvedilol in Inhibiting Doxorubicin-induced Cardiotoxicity
Maryam Nabati et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2017)
Erythropoietin activates SIRT1 to protect human cardiomyocytes against doxorubicin-induced mitochondrial dysfunction and toxicity
Lan Cui et al.
TOXICOLOGY LETTERS (2017)
Neferine ameliorates cardiomyoblast apoptosis induced by doxorubicin: possible role in modulating NADPH oxidase/ROS-mediated NFκB redox signaling cascade
Lohanathan Bharathi Priya et al.
SCIENTIFIC REPORTS (2017)
Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C
Ana Ludke et al.
PLOS ONE (2017)
Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity
Heba Samy Shoukry et al.
PLOS ONE (2017)
Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
Liqun Zhao et al.
SCIENTIFIC REPORTS (2017)
High-Sensitivity Troponin T and NT-proBNP Kinetics in Breast Cancer Chemotherapy
Pooja Advani et al.
CHEMOTHERAPY (2017)
A simple and sensitive high-performance liquid chromatography-electrochemical detection assay for the quantitative determination of monoamines and respective metabolites in six discrete brain regions of mice
Serena A. Allen et al.
BIOMEDICAL CHROMATOGRAPHY (2017)
Vitamin C mitigates oxidative/nitrosative stress and inflammation in doxorubicin-induced cardiomyopathy
Gauri Akolkar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Long-term use of pegylated liposomal doxorubicin to a cumulative dose of 4600mg/m2 in recurrent ovarian cancer
Adam Pendlebury et al.
ANTI-CANCER DRUGS (2017)
Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy
Yi Wei et al.
DRUG DELIVERY (2017)
Cardioprotection mechanism of mangiferin on doxorubicin-induced rats: Focus on intracellular calcium regulation
Femmi Dwinda Agustini et al.
PHARMACEUTICAL BIOLOGY (2016)
Carvedilol Administration Can Prevent Doxorubicin-Induced Cardiotoxicity: A Double-Blind Randomized Trial
Ahmad Tashakori Beheshti et al.
CARDIOLOGY (2016)
Baicalein alleviates doxorubicin-induced cardiotoxicity via suppression of myocardial oxidative stress and apoptosis in mice
Bidya Dhar Sahu et al.
LIFE SCIENCES (2016)
A Biophysical Systems Approach to Identifying the Pathways of Acute and Chronic Doxorubicin Mitochondrial Cardiotoxicity
Bernardo L. de Oliveira et al.
PLOS COMPUTATIONAL BIOLOGY (2016)
Nonpegylated liposomal doxorubicin: reduction in cardiotoxicity, although still severe alopecia
Corina van den Hurk et al.
ANTI-CANCER DRUGS (2015)
Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes
Esther Tahover et al.
ANTI-CANCER DRUGS (2015)
Protective effects of endothelin receptor A and B inhibitors against doxorubicin-induced cardiomyopathy
Matthias Schwebe et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Metabolism of doxorubicin to the cardiotoxic metabolite doxorubicinol is increased in a mouse model of chronic glutathione deficiency: A potential role for carbonyl reductase 3
Christopher M. Schaupp et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale et al.
CIRCULATION (2015)
Cardiac troponin-I, brain natriuretic peptide and endothelin-1 levels in a rat model of doxorubicin-induced cardiac injury
Erman Atas et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2015)
Doxorubicin: Comparison between 3-h continuous and bolus intravenous administration paradigms on cardio-renal axis, mitochondrial sphingolipids and pathology
Harriet Kamendi et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2015)
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
Luc Rochette et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2015)
Mitochondrial apoptosis-inducing factor is involved in doxorubicin-induced toxicity on H9c2 cardiomyoblasts
Ana C. Moreira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Dexrazoxane may prevent doxorubicin-induced DNA damage via depleting both Topoisomerase II isoforms
Shiwei Deng et al.
BMC CANCER (2014)
Effects of Histidine and N-Acetylcysteine on Doxorubicin-Induced Cardiomyopathy in Rats
Amir Abbas Farshid et al.
CARDIOVASCULAR TOXICOLOGY (2014)
Validation and clinical evaluation of a UHPLC method with fluorescence detector for plasma quantification of doxorubicin and doxorubicinol in haematological patients
Jonas Samuel Perez-Blanco et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2014)
Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: a review of the protective role of melatonin
Jenelle Govender et al.
JOURNAL OF PINEAL RESEARCH (2014)
Prevention of Anthracycline-Induced Cardiotoxicity
Pimprapa Vejpongsa et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
-Linolenic acid attenuates doxorubicin-induced cardiotoxicity in rats through suppression of oxidative stress and apoptosis
Xiaohua Yu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2013)
Liposomal drug delivery systems: From concept to clinical applications
Theresa M. Allen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
N-Acetylcysteine prevents doxorubucine-induced cardiotoxicity in rats
V. Arica et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2013)
Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study
Mehmet G. Kaya et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Simultaneous measurement of doxorubicin and reduced metabolite doxorubicinol by UHPLC-MS/MS in human plasma of HCC patients treated with TACE
Cristina Sottani et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Dexrazoxane Prevention of Anthracycline Cardiomyopathy
Rudolf Steiner et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Extraction protocol and mass spectrometry method for quantification of doxorubicin released locally from prodrugs in tumor tissue
Stuart Ibsen et al.
JOURNAL OF MASS SPECTROMETRY (2013)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Oktay Tacar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
Evaluation of Short-Term Use of N-Acetylcysteine as a Strategy for Prevention of Anthracycline-Induced Cardiomyopathy: EPOCH Trial - A Prospective Randomized Study
Sang-Ho Jo et al.
KOREAN CIRCULATION JOURNAL (2013)
Scintigraphic Techniques for Early Detection of Cancer Treatment-Induced Cardiotoxicity
Lioe-Fee de Geus-Oei et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2013)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Use of Cardiac Markers for Monitoring of Doxorubixin-induced Cardiotoxicity in Children With Cancer
Yupada Pongprot et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2012)
Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes
Ana Ludke et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang et al.
NATURE MEDICINE (2012)
Erythropoietin protects against doxorubicin-induced heart failure
Hania Ibrahim Ammar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Thrombopoietin protects against doxorubicin-induced cardiomyopathy, improves cardiac function, and reversely alters specific signalling networks
Kathy Yuen-Yee Chan et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
Cardioprotective effect of ascorbic acid on doxorubicin-induced myocardial toxicity in rats
A. H. M. Viswanatha Swamy et al.
INDIAN JOURNAL OF PHARMACOLOGY (2011)
CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes
Can M. Sag et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
The Cardioprotective Role of Probucol Against Anthracycline and Trastuzumab-Mediated Cardiotoxicity
Jonathan R. Walker et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2011)
Detection and characterization of translational research in cancer and cardiovascular medicine
David S. Jones et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Doxorubicin pathways: pharmacodynamics and adverse effects
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2011)
Scintigraphic Techniques for Early Detection of Cancer Treatment-Induced Cardiotoxicity
Lioe-Fee de Geus-Oei et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Maria Volkova et al.
CURRENT CARDIOLOGY REVIEWS (2011)
Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial
Steven E. Lipshultz et al.
LANCET ONCOLOGY (2010)
Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation
Amy V. Pointon et al.
PLOS ONE (2010)
Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death
O. Popelova et al.
BRITISH JOURNAL OF CANCER (2009)
Respiratory chain deficiency precedes the disrupted calcium homeostasis in chronic doxorubicin cardiomyopathy
Dirk Lebrecht et al.
CARDIOVASCULAR PATHOLOGY (2009)
Critical Role of Nuclear Calcium/Calmodulin-dependent Protein Kinase IIδB in Cardiomyocyte Survival in Cardiomyopathy
Gillian H. Little et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
Martee L. Hensley et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Topoisomerase IIα-dependent and -independent apoptotic effects of dexrazoxane and doxorubicin
Tiandong Yan et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Amrubicin: A Synthetic Anthracyclin Analogue in the Treatment of Extensive Stage Small Cell Lung Cancer
Chirag M. Shah
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2009)
ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes
Jiahao Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Ginkgo biloba extract 761 reduces doxorubicin-induced apoptotic damage in rat hearts and neonatal cardiomyocytes
Tsun-Jui Liu et al.
CARDIOVASCULAR RESEARCH (2008)
Anthracycline cardiotoxicity: From bench to bedside
Luca Gianni et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats
Azza I. Othman et al.
LIFE SCIENCES (2008)
Analysis of apoptosis by cytometry using TUNEL assay
Zbigniew Darzynkiewicz et al.
METHODS (2008)
Quantification of pegylated liposomal doxorubicin and doxorubicinol in rat plasma by liquid chromatography/electro spray tandem mass spectroscopy: Application to preclinical pharmacokinetic studies
Yanhong Liu et al.
TALANTA (2008)
Erythropoietin protects against doxorubicin-induced cardiomyopathy via a phosphatidylinositol 3-kinase-dependent pathway
Kyoung-Han Kim et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The endothelin receptor blocker bosentan inhibits doxorubicin-induced cardiomyopathy
Sandra Bien et al.
CANCER RESEARCH (2007)
The importance of endothelin-1 for vascular dysfunction in cardiovascular disease
Felix Boehm et al.
CARDIOVASCULAR RESEARCH (2007)
Topoisomerase IIβ-Mediated DNA double-strand breaks:: Implications in doxorubicin cardiotoxicity and prevention by dexrazoxane
Yi Lisa Lyu et al.
CANCER RESEARCH (2007)
Dexrazoxane prevents doxorubicin-induced long-term cardiotoxicity and protects myocardial mitochondria from genetic and functional lesions in rats
D. Lebrecht et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Potentiation of doxorubicin cardiotoxicity by iron loading in a rodent model
Gurusher S. Panjrath et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Cardiac troponin T following anthracycline chemotherapy in children and adolescents
S. J. Clark et al.
JOURNAL OF CHEMOTHERAPY (2007)
Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis
Kendall B. Wallace
CARDIOVASCULAR TOXICOLOGY (2007)
Anthracycline cardiotoxicity in long-term survivors of childhood cancer
Rebecca E. Scully et al.
CARDIOVASCULAR TOXICOLOGY (2007)
Doxorubicin-induccd cardiomyopathy from the cardiotoxic mechanisms to management
Genzou Takemura et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2007)
Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin
Sergio Gallegos-Castorena et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2007)
Protective effects of carvedilol against anthracycline-induced cardiomyopathy
Nihat Kalay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin
K Li et al.
CIRCULATION (2006)
Monitoring chemotherapy-induced cardiotoxicity: Role of cardiac nuclear imaging
Gurusher Singh Panjrath et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2006)
Preventive effect of erythropoietin on cardiac dysfunction in doxorubicin-induced cardiomyopathy
LH Li et al.
CIRCULATION (2006)
New insights into doxorubicin-induced cardiotoxicity: The critical role of cellular energetics
Malgorzata Tokarska-Schlattner et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Prevention of doxorubicin-induced cardiotoxicity by melatonin
E Oz et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2006)
Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats
A Puri et al.
EUROPEAN JOURNAL OF PEDIATRIC SURGERY (2005)
Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium
SV Kalivendi et al.
BIOCHEMICAL JOURNAL (2005)
Monitoring cardiac function in patients receiving doxorubicin
P Lu
SEMINARS IN NUCLEAR MEDICINE (2005)
Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide
H Mizutani et al.
LIFE SCIENCES (2005)
Recent advances with liposomes as pharmaceutical carriers
VP Torchilin
NATURE REVIEWS DRUG DISCOVERY (2005)
Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction
G Daugaard et al.
EUROPEAN JOURNAL OF HEART FAILURE (2005)
Dexrazoxane - A review of its use for cardioprotection during anthracycline chemotherapy
RS Cvetkokic et al.
DRUGS (2005)
Cardioprotective interventions for cancer patients receiving anthracyclines
EC van Dalen et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
MER O'Brien et al.
ANNALS OF ONCOLOGY (2004)
Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin
E Kismet et al.
PEDIATRIC BLOOD & CANCER (2004)
Troponin-T and brain natriuretic peptide as predictors for adriamycin-induced cardiomyopathy in rats
E Koh et al.
CIRCULATION JOURNAL (2004)
Quantification of doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy
RD Arnold et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
Mechanical unloading improves intracellular Ca2+ regulation in rats with doxorubicin-induced cardiomyopathy
T Takaseya et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia
SE Lipshultz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity
PJ Oliveira et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro
P Spallarossa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy
DL Santos et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2002)
Modification of doxorubicin-induced cardiotoxicity: manipulation of the dosage schedule
T Yeung et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2002)
Melatonin as an effective protector against doxorubicin-induced cardiotoxicity
XW Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Doxorubicin administration by continuous infusion is not cardioprotective: The Dana-Farber 91-01 acute lymphoblastic leukemia protocol
SE Lipshultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Role of exogenous melatonin in reducing the cardiotoxic effect of daunorubicin and doxorubicin in the rat
P Dziegiel et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2002)
Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction
T Nousiainen et al.
JOURNAL OF INTERNAL MEDICINE (2002)
Increased plasma endothelin-1 and cardiac nitric oxide during doxorubicin-induced cardiomyopathy
MM Sayed-Ahmed et al.
PHARMACOLOGY & TOXICOLOGY (2001)
Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer
F Hayakawa et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2001)
A novel pharmacological action of ET-1 to prevent the cytotoxicity of doxorubicin in cardiomyocytes
T Suzuki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2001)
Apoptosis in adriamycin cardiomyopathy and its modulation by probucol
D Kumar et al.
ANTIOXIDANTS & REDOX SIGNALING (2001)
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin
M Lotem et al.
ARCHIVES OF DERMATOLOGY (2000)
Pegylated liposomal doxorubicin (doxil):: Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2
T Safra et al.
ANNALS OF ONCOLOGY (2000)
The biosynthesis and functional role of cardiolipin
M Schlame et al.
PROGRESS IN LIPID RESEARCH (2000)
Doxorubicin metabolism and toxicity in human myocardium: Role of cytoplasmic deglycosidation and carbonyl reduction
S Licata et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2000)
Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats
EH Herman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2000)
Cardiotoxicity of doxorubicin and other anthracycline derivatives
D Jain
JOURNAL OF NUCLEAR CARDIOLOGY (2000)
Modulatory effects of melatonin and vitamin E on doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice
MHA Wahab et al.
TUMORI (2000)
分享论文
